Broadcasting Live on Wednesday April 19th at 3:45 PM ET TARRYTOWN, NY - April 19, 2023 - PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (“APT”) for the treatment of disorders with intractable neurologic symptoms, today announced that Chief Executive Officer… Read More..

Interim financing to bridge to advancement of ongoing buyside M&A discussions and anticipated favorable midyear performance metrics for faidr M&A strategy will accelerate Auddia's plans to scale, acquire subscribers, expand internationally, and deploy to broader platforms, including automobiles BOULDER, CO, April 18, 2023 (GLOBE NEWSWIRE) -- Auddia Inc. (NASDAQ:AUUD) (NASDAQ:AUUDW) ("Auddia"… Read More..

BELTSVILLE, Md., April 11, 2023 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will present at the 22nd Annual Needham Virtual Healthcare Conference on Wednesday, April 19th, at 10:15 am ET. A live audio webcast will… Read More..